On May 23, the Council of the EU adopted a set of conclusions on scholarly publishing that, if followed through, would spell the end for academic publishers and scholarly journals as we know them. On the same day, the adoption was followed by a joint statement of support by the largest and most influential research organizations in Europe.
Data broker RELX is represented on Twitter by their Chief Communications Officer Paul Abrahams. Due to RELX subsidiary Elsevier being one of the largest publishers of academic journals, Dr. Abrahams frequently engages with academics on the social media platform.
The market power of academic publishers has been a concern for all those academic fields where publication in scholarly journals is the norm. For most non-economist researchers, the anti-trust aspects of academic publishing are likely confusing and opaque. For instance, libraries and consortia are exempted from organizing tenders for their publication needs as each article exists only in one journal with one publisher.
According to a recent study, employee surveillance is rampant in today’s corporate work environment. This study documents how, often under the pretense of cybersecurity or risk analysis (sort of like academic publishers, actually), companies analyze the behavioral data they collect from their employees to help them make “evidence-led”, i.e., algorithmic employment decisions.
There has been some outrage at the announcement that Nature is following through with their 2004 declaration of charging ~10k ($/€) in article processing charges (APCs). However, not only have these charges been 16 years in the making but the original declaration was made not on some obscure blog, but at a UK parliamentary inquiry. So nobody could rightfully claim that we couldn’t have seen this development coming from miles away.
Last week, there was a lot of outrage at the announcement of Nature’s new pricing options for their open access articles. People took to twitter to voice their, ahem, concern. Some examples: There are many more that all express their outrage at the gall of Nature to charge their authors these sums,. even Forbes interviewed some of them.
Just before Christmas 2019, the Washington Post reported, based on “people familiar with the matter”, that the US Justice Department were investigating the Sci-Hub founder Alexandra Elbakyan for potentially “working with Russian intelligence to steal U.S. military secrets from defense contractors”. Besides such a highly unusual connection, the article also reiterated unsubstantiated (but mainly circulated by publishers) allegations that access
The New England journal of Medicine has come out strongly against Open Access. Apparently, this journal does not seem to value access to medical information very highly. This lack of valuation could be due to several reasons.
Time and time again, academic publishers have managed to create the impression that publishing incurs a lot of costs which justify the outrageous prices they charge, be that US$11M p.a. for an Elsevier Big Deal subscription or an article processing charge (APC) of US$5,200 for a Nature Communications article.
Notwithstanding the barrage of criticisms and warnings from every corner of the scholarly community, various initiatives, mainly in the Netherlands, Finland, Germany, France and the UK, continue their efforts for a smooth transition from subscriptions to open access without any further disruptions.